ZUSAMMENSETZUNG MIT DUTASTERID

Patent europeic · EP3893845 · En vigur

Inscripziun en il register

Numer da publicaziun: EP3893845
Numer da la dumonda: EP19895962
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: En vigur
Scrittira da patent: Concedì
Annunzià: 13-12-2019
Publitgà: 20-10-2021
Concedì: 20-08-2025
La protecziun finescha il pli tard: 12-12-2039
Proxima taxa annuala scadenta: 31-12-2026
Classas IPC: A61K 31/58 (2006.01)
A61K 9/00 (2006.01)
A61K 9/08 (2006.01)
A61K 47/22 (2006.01)
A61K 47/12 (2006.01)
A61K 47/14 (2017.01)
A61K 47/20 (2006.01)
A61K 47/10 (2017.01)
A61K 47/44 (2017.01)
A61P 13/08 (2006.01)
A61P 17/14 (2006.01)
A61P 5/24 (2006.01)
Prioritad: KR 20180162464 14.12.2018
Dumonda PCT: PCT/KR2019/017738 13.12.2019
Publicaziun PCT: WO2020/122681 18.06.2020
Lingua da l’annunzia: englais
Funtauna: Swissreg

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

01-07-2026
Midada
Published in Swissreg on 01.07.2026
06-01-2026
Next annual fee due on
Next annual fee due on
31.12.2025 → 31.12.2026
Published in Swissreg on 06.01.2026
17-10-2025
Represchentant inscrit
Representative
HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel
Published in Swissreg on 17.10.2025
20-08-2025
Concedì
Specification status
Non-published patent application → Granted patent
Status of protective title
Initiated → Active
Published in Swissreg on 20.08.2025

8, Chungjeong-ro Seodaemun-gu, Seoul 03742, KR

HGF GmbH OBC Suisse AG

Aeschengraben 29, 4051 Basel